🇺🇸 FDA
Patent

US 11213549

Compositions and method for treating primary sclerosing cholangitis and related disorders

granted A61KA61K35/24A61K35/38

Quick answer

US patent 11213549 (Compositions and method for treating primary sclerosing cholangitis and related disorders) held by Finch Therapeutics Holdings LLC expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Finch Therapeutics Holdings LLC
Grant date
Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/24, A61K35/38, A61K9/0053, A61K9/4891